Results Of Phase Iii Trial Of Rh-Endostatin (Yh-16) In Advanced Non-Small Cell Lung Cancer (Nsclc) Patients.Yanchun Sun,Junyi Wang, Yueju Liu,Xiaolan Song, Yali Zhang,Kuanching Li,Y Zhu,Qing Zhou, Lei You, Chengcheng YaoJOURNAL OF CLINICAL ONCOLOGY(2005)引用 118|浏览11暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要